IPC분류정보
국가/구분 |
United States(US) Patent
등록
|
국제특허분류(IPC7판) |
|
출원번호 |
US-0932149
(2007-10-31)
|
등록번호 |
US-8260416
(2012-09-04)
|
우선권정보 |
IL-116699 (1996-01-08); IL-119261 (1996-09-17) |
발명자
/ 주소 |
- Ben-Haim, Shlomo
- Darvish, Nissim
- Fenster, Maier
- Yuval, Mika
|
출원인 / 주소 |
|
대리인 / 주소 |
|
인용정보 |
피인용 횟수 :
14 인용 특허 :
383 |
초록
▼
A method of modifying the force of contraction of at least a portion of a heart chamber, including providing a subject having a heart, comprising at least a portion having an activation, and applying a non-excitatory electric field having a given duration, at a delay after the activation, to the por
A method of modifying the force of contraction of at least a portion of a heart chamber, including providing a subject having a heart, comprising at least a portion having an activation, and applying a non-excitatory electric field having a given duration, at a delay after the activation, to the portion, which causes the force of contraction to be increased by a least 5%.
대표청구항
▼
1. A method of treating reduced cardiac output of a beating heart, the method comprising applying an electric signal to cardiac tissue which is applied during an absolute refractory period and which is adapted to exert positive control to cardiac tissue, wherein said applying comprises applying said
1. A method of treating reduced cardiac output of a beating heart, the method comprising applying an electric signal to cardiac tissue which is applied during an absolute refractory period and which is adapted to exert positive control to cardiac tissue, wherein said applying comprises applying said signal to a non-arrhythmic segment of a beating heart for at least 100 beats out of 50,000 consecutive beats. 2. A method according to claim 1, wherein said applying comprises applying said signal at least 1000 beats out of 50,000 consecutive beats. 3. A method according to claim 1, wherein said applying comprises applying said signal at least 4000 beats out of 50,000 consecutive beats. 4. A method according to claim 1, wherein said applying causes an increase in flow volume of at least 5%. 5. A method according to claim 1, wherein said applying comprises determining a state of reduced cardiac output and applying said signal in response to said determining. 6. A method according to claim 1, comprising modifying said applying in response to feedback indicating cardiac output. 7. A method according to claim 1, wherein said applying comprises applying said signal for between 3 and 5000 consecutive beats. 8. A method according to claim 1, wherein said applying comprises applying said signal periodically according to a therapy schedule. 9. A method according to claim 8, wherein said applying comprises applying said signal on a daily basis. 10. A method according to claim 1, wherein said applying causes an increase in cardiac output. 11. A method according to claim 1, wherein said applying causes an increase in contractility of at least 5%. 12. A method for modifying cardiac activity, the method comprising repeatedly applying a non-excitatory signal with a defined control sequence for a finite amount of time including a plurality of consecutive heart beats to a cardiac tissue of a beating heart, during an absolute refractory period of said tissue, wherein said applying comprises applying said signal to a non-arrhythmic segment of a beating heart for at least 100 beats out of 50,000 consecutive beats. 13. A method according to claim 12, wherein the defined control sequence is not responsive to a signal from a sensor. 14. A method according to claim 12, wherein the control sequence is defined in terms of heartbeats. 15. A method according to claim 12, wherein modification of the cardiac activity persists after the finite amount of time is over. 16. A method according to claim 12, wherein the defined control sequence specifies a first number of beats in which a first control logic is applied and a second number of beats in which a second, different, control logic is applied. 17. A method according to claim 16, wherein said applying is according to a predetermined control sequence. 18. A method according to claim 16, wherein said applying is responsive to a cardiac output parameter. 19. A method according to claim 16, wherein the control sequence specifies application of the signal during 1% to 70% of heartbeats. 20. A method according to claim 16, wherein the control sequence specifies rest periods during which no signal is applied. 21. A method according to claim 16, wherein said applying comprises modifying the control sequence responsive to the output of a parametric sensor. 22. A method according to claim 12, comprising alternating said defined control sequence wherein a first control logic is applied for a first number of beats with at least a second, different, defined control sequence where a second control logic is applied for a second number of beats. 23. A method of ameliorating a clinical severity of reduced cardiac output of a beating heart in a patient with a long term therapeutic goal of increased cardiac output, the method comprising: repeatedly applying a non-excitatory electric field to at least a portion of a beating heart, the electric field characterized by a magnitude, shape, duty cycle, phase, frequency and duration suitable to obtain an increase in stroke volume,wherein said applying comprises applying said signal to a non-arrhythmic segment of a beating heart for at least 100 beats out of 50,000 consecutive beats. 24. A method according to claim 23, wherein the electric field is altered in response to an output from a sensor. 25. A method according to claim 24, wherein the sensor includes at least one sensor type selected from the group consisting of a pH sensor, an oxygen saturation sensor, a carbon dioxide saturation sensor, blood flow sensor, an acceleration sensor, a respiration sensor and a pressure sensor. 26. A method according to claim 23, wherein the electric field is applied at a time at which it is unable to generate a propagating action potential. 27. A method according to claim 23, wherein the electric field is adapted to influence a physiologic property of cardiac cells. 28. A method according to claim 27, wherein the physiologic property comprises calcium ion transport. 29. A method according to claim 23, comprising ceasing the applying when a desired change a distribution of muscle mass in the heart is achieved. 30. A method according to claim 23, performed on an ongoing basis by an implanted apparatus as a therapy for reduced cardiac output. 31. A method of cardiac modeling, the method comprising: (a) applying a non-excitatory electric field to at least a portion of a heart to change a distribution of muscle mass in the heart; and(b) ceasing to apply the non excitatory electric field after a desired change in distribution of muscle mass is achieved,wherein said applying comprises applying said signal to a non-arrhythmic segment of a beating heart for at least 100 beats of a non-arrhythmically beating heart out of 50,000 consecutive beats.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.